Teleflex Incorporated (TFX)

Market Cap	5.61B
Revenue (ttm)	3.19B
Net Income (ttm)	-327.97M
Shares Out	44.19M
EPS (ttm)	-7.26
PE Ratio	n/a
Forward PE	8.59
Dividend	$1.36 (1.07%)
Ex-Dividend Date	Nov 14, 2025

Volume	664,900
Open	127.43
Previous Close	127.25
Day's Range	125.72 - 127.97
52-Week Range	102.58 - 185.94
Beta	0.95
Analysts	Hold
Price Target	138.00 (+8.76%)
Earnings Date	Nov 6, 2025

About TFX

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous bone access systems for the administration of intravenous therapies, the measurement of blood pressure, and the collection of blood samples. The company also offers interventional products, including various co...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1943
• Employees: 14,100
• Stock Exchange: NYSE
• Ticker Symbol: TFX
• Website: https://www.teleflex.com

Financial Performance

In 2024, Teleflex's revenue was $3.05 billion, an increase of 2.45% compared to the previous year's $2.97 billion. Earnings were $69.68 million, a decrease of -80.45%.

Analyst Summary

According to 10 analysts, the average rating for TFX stock is "Hold." The 12-month stock price target is $138.0, which is an increase of 8.76% from the latest price.

Price Target

$138.0

(8.76% upside)

Analyst Consensus: Hold